JoAnn T Tschanz
Overview
Explore the profile of JoAnn T Tschanz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
2976
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schliep K, Thornhill J, Tschanz J, Facelli J, Ostbye T, Sorweid M, et al.
BMC Med Inform Decis Mak
. 2024 Oct;
24(1):316.
PMID: 39468568
Introduction: Clinical notes, biomarkers, and neuroimaging have proven valuable in dementia prediction models. Whether commonly available structured clinical data can predict dementia is an emerging area of research. We aimed...
2.
Farrer T, Bigler E, Tsui-Caldwell Y, Abildskov T, Tschanz J, Welsh-Bohmer K
Appl Neuropsychol Adult
. 2023 Dec;
:1-7.
PMID: 38052027
Objective: Examine the association between neuropsychologically assessed executive function and clinically identifiable white matter burden from magnetic resonance imaging, using a visual rating system (Scheltens Rating System) applied to the...
3.
Kauzor K, Drewel M, Gonzalez H, Rattinger G, Hammond A, Wengreen H, et al.
Int Psychogeriatr
. 2023 May;
35(11):653-663.
PMID: 37246509
Objectives: Among people with dementia, poor nutritional status has been associated with worse cognitive and functional decline, but few studies have examined its association with neuropsychiatric symptoms (NPS). We examined...
4.
Schliep K, Ju S, Foster N, Smith K, Varner M, Ostbye T, et al.
Alzheimers Dement
. 2021 Dec;
18(10):1812-1823.
PMID: 34873816
Introduction: Retrospective studies using administrative data may be an efficient way to assess risk factors for dementia if diagnostic accuracy is known. Methods: Within-individual clinical diagnoses of Alzheimer's disease (AD)...
5.
Tschanz J, Hammond A
Int Psychogeriatr
. 2020 Mar;
32(3):303-306.
PMID: 32192560
No abstract available.
6.
Matyi J, Rattinger G, Schwartz S, Buhusi M, Tschanz J
Menopause
. 2019 Oct;
26(12):1366-1374.
PMID: 31613825
Objective: Prevalence of Alzheimer's disease (AD) is higher for women, possibly influenced by sex-dependent effects of the estrogen. We examined the association between estrogen and cognitive decline in over 2,000...
7.
Sanders C, Rattinger G, DeBerard M, Hammond A, Wengreen H, Kauwe J, et al.
J Gerontol A Biol Sci Med Sci
. 2019 Sep;
75(9):1633-1642.
PMID: 31504225
Research indicates that lifestyle and genetic factors influence the course of cognitive impairment in aging, but their interactions have not been well-examined. This study examined the relationship between physical activity...
8.
Burhanullah M, Tschanz J, Peters M, Leoutsakos J, Matyi J, Lyketsos C, et al.
Am J Geriatr Psychiatry
. 2019 Jun;
28(1):64-71.
PMID: 31186157
Introduction: There has been considerable progress in identifying early cognitive and biomarker predictors of Alzheimer's disease (AD). Neuropsychiatric symptoms (NPS) are common in AD and appear to predict progression after...
9.
Wright S, Jensen S, Cockriel K, Davis B, Tschanz J, Munger R, et al.
Neurobiol Aging
. 2019 Apr;
84:242.e1-242.e6.
PMID: 30975575
3-Hydroxy-3-methylglutaryl coenzyme A reductase is associated with monitoring cholesterol levels. The presence of the single-nucleotide polymorphism rs3846662 introduces alternative splicing at exon 13; the exclusion of this exon leads to...
10.
Rozum W, Cooley B, Vernon E, Matyi J, Tschanz J
Int J Geriatr Psychiatry
. 2019 Apr;
34(7):1087-1094.
PMID: 30945374
Objectives: To examine the prevalence of neuropsychiatric symptoms (NPS) and cognitive correlates in severe dementia. Methods: A population-based sample of 56 individuals with severe dementia (85.7% Alzheimer's type; 67.9% female)...